Bayer Loses Bid for a New Trial in $80 Million Roundup Case

(Bloomberg) -- Bayer AG won’t get a new trial in the case of a California man who was awarded $80 million by a jury after it found exposure to the company’s Roundup weed killer caused his cancer.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.